openPR Logo
Press release

RNA Sequencing Market - Government Initiatives in Population Sequencing and Emerging Markets Such As China & India Offer Major Opportunities for the Market Growth

02-26-2019 10:26 AM CET | Health & Medicine

Press release from: Allied Market Research

RNA Sequencing Market

RNA Sequencing Market

RNA sequencing or whole-transcriptome shotgun sequencing is the process of identifying the presence and amount of RNA present in a biological sample. You can analyze cell transcriptome constantly changing. Gene fusion, post-transcriptional modification and splicing confirmation; Recognize exon / intron boundaries of eukaryotic genes.

Leading the growth of the global RNA sequence analysis market with advances in sequencing technology, increased acceptance of NGS technology, increased partnerships and collaboration. However, market growth is constrained by the lack of skilled professionals and the problems associated with storing sequencing data. Government arrangements for population arrangements and emerging markets such as China and India provide significant growth opportunities for market growth.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/2980

The market is dominated by players such as
• Affymetrix Inc.
• Thermo Fisher Scientific Inc.
• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• GE Healthcare
• Illumina Inc.
• Qiagen N.V.
• F. Hoffmann-La Roche Ltd.
• Sigma Aldrich
• Fluidigm Corporation

The RNA sequencing market in segmented on the basis of products & services, technology, application, end user, and region. Based on products & services, the market is categorized into sample preparation, sequencing platforms & consumables for RNA sequencing; RNA sequencing services; and data analysis, storage, and management. Sample preparation is subsegmented into application and method.

Based on technology, the market is classified into sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, and nanopore sequencing. Applications covered in the study include de novo transcriptome assembly, expression profiling analysis, variant calling & transcriptome epigenetics, and small RNA sequencing.

According to end user, the market is divided into research centers and academic & government institutes, hospitals & clinics, pharmaceutical & biotechnology companies, and others (nonprofit organizations, agrigenomics organizations, and consumer genomics companies). Geographically, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/2980

Key Benefits
• The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
• Comprehensive analysis of all geographical regions is provided, which helps to determine the prevailing opportunities.
• Key players are profiled and their strategies are analyzed thoroughly, which help to understand competitive outlook of the global market.
• The report offers a quantitative analysis from 2017 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
• Exhaustive analysis of the RNA sequencing market by type helps to understand the types of sequencing technologies that are currently being used along with the variants that are expected to gain prominence in the future.

Access Full Summery @ https://www.alliedmarketresearch.com/rna-sequencing-market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release RNA Sequencing Market - Government Initiatives in Population Sequencing and Emerging Markets Such As China & India Offer Major Opportunities for the Market Growth here

News-ID: 1616752 • Views: 179

More Releases from Allied Market Research

Proximity and Displacement Sensors Market - 2020: COVID-19 Scenario, Growth Oppo …
The report titled, “Proximity and Displacement Sensors Market By Type (Inductive, Photoelectric, Capacitive, Ultrasonic, Magnetic & LVDT sensors) and Application (Parking Sensor Systems, Ground Proximity Warning System, Anti-aircraft warfare, Assembly line automation, Vibration monitoring system, Roller coasters, Conveyor systems) - Global Opportunity Analysis and Industry Forecast, 2020-2027” published by Allied Market Research, says that proximity and displacement sensors market is expected to grow sustainably by 2027. The report offers an
Asia-Pacific ATM Market - 2020: COVID-19 Impact, Growth Opportunities and Busine …
The report titled, “Asia-Pacific ATM Market By Solutions (ON site ATMs, Off site ATMs, Work site ATMs, Mobile ATMs, Managed services) and by Type (Conventional ATM, Brown label ATM, White label ATM, Smart ATM, Cash dispenser) - Opportunity Analysis and Industry Forecast, 2020-2027” published by Allied Market Research, says that Asia-Pacific ATM market is expected to grow sustainably by 2027. The report offers an extensive market analysis focusing on key
Travel Insurance Market - 2020: COVID-19 Scenario, Market Share, Growth Opportun …
The report titled, “Travel Insurance Market By Insurance Cover (SingleTrip Travel Insurance, Annual Multi-Trip Travel Insurance, and Long-Stay Travel Insurance), Distribution Channel (Insurance Intermediaries, Insurance Companies, Banks, Insurance Brokers, and Insurance Aggregators), and End User (Senior Citizens, Education Travelers, Business Travelers, Family Travelers, and Others): Global Opportunity Analysis and Industry Forecast, 2020-2027” published by Allied Market Research, says that travel insurance market is expected to grow sustainably by 2027. The
Crystal Oscillator Market – 2020: COVID-19 Impact, Market Share, Growth Opport …
The report titled, “Crystal Oscillator Market By Technology (AT Cut, BT Cut, and SC Cut), Type (Voltage-Controlled Crystal Oscillator, Temperature-Compensated Crystal Oscillator, Oven-Controlled Crystal Oscillator, and Others), Mounting Scheme (Surface Mount and Thru-Hole), and Industry Vertical (Electronics, IT & Telecommunication, Military & Defense, Automotive & Transport, and Others) - Global Opportunity Analysis and Industry Forecast, 2020-2027” published by Allied Market Research, says that crystal oscillator market is expected to grow

All 5 Releases


More Releases for RNA

RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year. Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved
Automated DNA/RNA Isolation System Market Overview Till 2018-2023
Future Market Reports on Global Automated DNA/RNA Isolation System 2018 Research Report presents a professional and complete analysis of on the current Industry situation. The Global report includes Automated DNA/RNA Isolation System Revenue, market Share, industry volume, Trends, Growth aspects. It analyses the important factors of the based on present industry situations, demands, business strategies utilized by Automated DNA/RNA Isolation System market players and the future prospects from various angles
RNA Sequencing: Technologies and Analyses of Global Market Trends
"The Latest Research Report RNA Sequencing: Technologies and Global Markets provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" The global RNA-Sequencing market reached nearly $1.1 billion in 2015, and should reach $1.2 billion in 2016 and $2.1 billion in 2020, registering a compound annual growth rate (CAGR) of 14.9%. The tools and reagents segment should reach over $1.0 billion in 2020 from $566.8
Topics Presented this February 2018 at RNA Therapeutics
SMi’s RNA Therapeutics will be bringing a global presence from MHRA, The RNA Institute, MiNA Therapeutics, AstraZeneca R&D, GSK, Sanofi, CureVac and more. With an agenda full of exciting and new approaches, examine the latest developments in delivery systems for RNA Therapeutics, including Exosomes, Nanocomplexes and Platform Delivery Approaches and patenting RNA Therapeutics. www.therapeutics-rna.com/opr Spotlight: Want to learn about exploiting exosomes for therapeutic use in patients with cystic fibrosis? Have questions answered during
RNA Analysis Market worth 3.62 billion USD by 2021
RNA Analysis Market size was around USD 1.89 billion in 2016. It is expected to grow at a CAGR of 13.9% to reach USD 3.62 billion by 2021. The market is mainly driven by the increasing technological advancements, increasing investment in research and development by biotechnology and pharmaceutical companies, rising government and private funding, and growing preference for personalized medicines. However, lack of skilled professionals in the transcriptomics field and lack
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018! Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led